FR2149302B1 - - Google Patents

Info

Publication number
FR2149302B1
FR2149302B1 FR7130254A FR7130254A FR2149302B1 FR 2149302 B1 FR2149302 B1 FR 2149302B1 FR 7130254 A FR7130254 A FR 7130254A FR 7130254 A FR7130254 A FR 7130254A FR 2149302 B1 FR2149302 B1 FR 2149302B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7130254A
Other languages
French (fr)
Other versions
FR2149302A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7130254A priority Critical patent/FR2149302A1/fr
Priority to DK401272AA priority patent/DK130992B/da
Priority to CA149,835A priority patent/CA975756A/en
Priority to JP8219772A priority patent/JPS5616800B2/ja
Publication of FR2149302A1 publication Critical patent/FR2149302A1/fr
Application granted granted Critical
Publication of FR2149302B1 publication Critical patent/FR2149302B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR7130254A 1971-08-19 1971-08-19 21-methyl pregnadienes prepn - used as progestomimetics Granted FR2149302A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR7130254A FR2149302A1 (en) 1971-08-19 1971-08-19 21-methyl pregnadienes prepn - used as progestomimetics
DK401272AA DK130992B (da) 1971-08-19 1972-08-15 Fremgangsmåde til fremstilling af 21-methylpregna-4,9-dienderivater.
CA149,835A CA975756A (en) 1971-08-19 1972-08-17 Procede de preparation des derives 21-methyles du pregnane
JP8219772A JPS5616800B2 (da) 1971-08-19 1972-08-18

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7130254A FR2149302A1 (en) 1971-08-19 1971-08-19 21-methyl pregnadienes prepn - used as progestomimetics

Publications (2)

Publication Number Publication Date
FR2149302A1 FR2149302A1 (en) 1973-03-30
FR2149302B1 true FR2149302B1 (da) 1974-09-06

Family

ID=9082025

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7130254A Granted FR2149302A1 (en) 1971-08-19 1971-08-19 21-methyl pregnadienes prepn - used as progestomimetics

Country Status (4)

Country Link
JP (1) JPS5616800B2 (da)
CA (1) CA975756A (da)
DK (1) DK130992B (da)
FR (1) FR2149302A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2385737A1 (fr) * 1977-04-01 1978-10-27 Roussel Uclaf Nouveaux steroides, leur procede de preparation et leur application dans la synthese de steroides marques au tritium
FR2374335A1 (fr) * 1976-12-14 1978-07-13 Roussel Uclaf Nouveaux steroides, leur procede de preparation et leur application dans la synthese de steroides marques au tritium
FR2430953A1 (fr) * 1978-07-13 1980-02-08 Roussel Uclaf Nouveaux derives 3,20-dioxo 4,9-diene 21-hydroxyle, leur procede de preparation et leur application comme medicaments
FR2692267B1 (fr) * 1992-06-11 1995-05-19 Roussel Uclaf Nouveau procédé de préparation de composés stéroïdes 20-céto 21alpha-hydroxy et intermédiaires.
ITMI20042001A1 (it) 2004-10-21 2005-01-21 Ind Chimica Srl Processo per la preparazione di 21-idrossi steroidi con controllo della distribuzione epimerica nella posizione c-21

Also Published As

Publication number Publication date
CA975756A (en) 1975-10-07
DK130992B (da) 1975-05-12
DK130992C (da) 1975-10-13
FR2149302A1 (en) 1973-03-30
JPS4829756A (da) 1973-04-19
JPS5616800B2 (da) 1981-04-18

Similar Documents

Publication Publication Date Title
AU442517B2 (da)
ATA136472A (da)
DK130992C (da)
AU2658571A (da)
AU2691671A (da)
AU2684071A (da)
AU2742671A (da)
AU2726271A (da)
AU2894671A (da)
AU2941471A (da)
AU2952271A (da)
AU3005371A (da)
AU2837671A (da)
AU2854371A (da)
AU3038671A (da)
AU3025871A (da)
AU2588771A (da)
AU2963771A (da)
AU2654071A (da)
AU2503871A (da)
AU2940971A (da)
AU2938071A (da)
AU2930871A (da)
AU2927871A (da)
AU2907471A (da)

Legal Events

Date Code Title Description
ST Notification of lapse